title: Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging.
abstract: Several imaging modalities are suitable for in vivo molecular neuroimaging, but the blood-brain barrier (BBB) limits their utility by preventing brain delivery of most targeted molecular probes. We prepared biodegradable nanocarrier systems made up of poly(n-butyl cyanoacrylate) dextran polymers coated with polysorbate 80 (PBCA nanoparticles) to deliver BBB-impermeable molecular imaging probes into the brain for targeted molecular neuroimaging. We demonstrate that PBCA nanoparticles allow in vivo targeting of BBB-impermeable contrast agents and staining reagents for electron microscopy, optical imaging (multiphoton), and whole brain magnetic resonance imaging (MRI), facilitating molecular studies ranging from individual synapses to the entire brain. PBCA nanoparticles can deliver BBB-impermeable targeted fluorophores of a wide range of sizes: from 500-Da targeted polar molecules to 150,000-Da tagged immunoglobulins into the brain of living mice. The utility of this approach is demonstrated by (i) development of a "Nissl stain" contrast agent for cellular imaging, (ii) visualization of amyloid plaques in vivo in a mouse model of Alzheimer's disease using (traditionally) non-BBB-permeable reagents that detect plaques, and (iii) delivery of gadolinium-based contrast agents into the brain of mice for in vivo whole brain MRI. Four-dimensional real-time two-photon and MR imaging reveal that brain penetration of PBCA nanoparticles occurs rapidly with a time constant of ∼18 min. PBCA nanoparticles do not induce nonspecific BBB disruption, but collaborate with plasma apolipoprotein E to facilitate BBB crossing. Collectively, these findings highlight the potential of using biodegradable nanocarrier systems to deliver BBB-impermeable targeted molecular probes into the brain for diagnostic neuroimaging.
authors: Department of Neurology, Massachusetts General Hospital and Harvard Medical School , Charlestown, MA 02129, USA.
authors: Robert M
authors: RM
authors: Koffie
authors: Christian T
authors: CT
authors: Farrar
authors: Laiq-Jan
authors: LJ
authors: Saidi
authors: Christopher M
authors: CM
authors: William
authors: Bradley T
authors: BT
authors: Hyman
authors: Tara L
authors: TL
authors: Spires-Jones
mesh_terms: D000470:Alkaloids / Q000494:pharmacology; D000544:Alzheimer Disease / Q000378:metabolism; D000818:Animals; D001057:Apolipoproteins E / Q000097:blood; D001812:Blood-Brain Barrier; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D003287:Contrast Media / Q000494:pharmacology; D005682:Gadolinium / Q000737:chemistry; D007211:Indoles / Q000494:pharmacology; D008279:Magnetic Resonance Imaging / Q000379:methods*; D051379:Mice; D053758:Nanoparticles / Q000737:chemistry*; D055095:Optics and Photonics; D017785:Photons; D011804:Quinolines / Q000494:pharmacology; D014343:Trypan Blue / Q000494:pharmacology
chemical_list: C093071:3,8-diamino-10H-quindoline; D000470:Alkaloids; D001057:Apolipoproteins E; D003287:Contrast Media; D007211:Indoles; D011804:Quinolines; D005682:Gadolinium; D014343:Trypan Blue